The DOI matches its Crossref record; 54 of the 54 references it cites were found in a registry or an index.
Sensitivity of Human Immunodeficiency Virus Type 1 to the Fusion Inhibitor T-20 Is Modulated by Coreceptor Specificity Defined by the V3 Loop of gp120
Open accessAbstract
T-20 is a synthetic peptide that potently inhibits replication of human immunodeficiency virus type 1 by interfering with the transition of the transmembrane protein, gp41, to a fusion active state following interactions of the surface glycoprotein, gp120, with CD4 and coreceptor molecules displayed on the target cell surface. Although T-20 is postulated to interact with an N-terminal heptad repeat within gp41 in a trans -dominant manner, we show here that sensitivity to T-20 is strongly influenced by coreceptor specificity. When 14 T-20-naive primary isolates were analyzed for sensitivity to T-20, the mean 50% inhibitory concentration (IC 50 ) for isolates that utilize CCR5 for entry (R5 viruses) was 0.8 log 10 higher than the mean IC 50 for CXCR4 (X4) isolates ( P = 0.0055). Using NL4.3-based envelope chimeras that contain combinations of envelope sequences derived from R5 and X4 viruses, we found that determinants of coreceptor specificity contained within the gp120 V3 loop modulate this sensitivity to T-20. The IC 50 for all chimeric envelope viruses containing R5 V3 sequences was 0.6 to 0.8 log 10 higher than that for viruses containing X4 V3 sequences. In addition, we confirmed that the N-terminal heptad repeat of gp41 determines the baseline sensitivity to T-20 and that the IC 50 for viruses containing GIV at amino acid residues 36 to 38 was 1.0 log 10 lower than the IC 50 for viruses containing a G-to-D substitution. The results of this study show that gp120-coreceptor interactions and the gp41 N-terminal heptad repeat independently contribute to sensitivity to T-20. These results have important implications for the therapeutic uses of T-20 as well as for unraveling the complex mechanisms of virus fusion and entry.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Identification of a reservoir for HIV-1 in patients on highly active antiretroviral therapy
Finzi, D., Hermankova, M., Pierson, T., Carruth, L. M., Buck, C., Chaisson, R. E., Quinn, T. C., Chadwick, K., Margolick, J., Brookmeyer, R., et al. (1997) · Science · doi:10.1126/science.278.5341.1295 · Cited by 3,098
Kwong, P. D., Wyatt, R., Robinson, J., Sweet, R. W., Sodroski, J., & Hendrickson, W. A. (1998) · Nature · doi:10.1038/31405 · Cited by 2,964
Adachi, A., Gendelman, H. E., Koenig, S., Folks, T., Willey, R., Rabson, A., & Martin, M. A. (1986) · Journal of Virology · doi:10.1128/jvi.59.2.284-291.1986 · Cited by 2,834
Recovery of replication-competent HIV despite prolonged suppression of plasma viremia
Wong, J. K., Hezareh, M., Günthard, H. F., Havlir, D. V., Ignacio, C. C., Spina, C. A., & Richman, D. D. (1997) · Science · doi:10.1126/science.278.5341.1291 · Cited by 2,186 · cited 1×
“Second, administration of T-20 as part of an antiretroviral regimen in patients with early disease might delay the emergence of more pathogenic strains of HIV-1 that are associated with CXCR4 specificity if viral replication is not completely suppressed (9, 12, 16, 58).”
BackgroundChemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease
Berger, E. A., Murphy, P. M., & Farber, J. M. (1999) · Annual Review of Immunology · doi:10.1146/annurev.immunol.17.1.657 · Cited by 2,180
Presence of an inducible HIV-1 latent reservoir during highly active antiretroviral therapy
Chun, T.-W., Stuyver, L., Mizell, S. B., Ehler, L. A., Mican, J. A. M., Baseler, M., Lloyd, A. L., Nowak, M. A., & Fauci, A. S. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.24.13193 · Cited by 1,977
Core Structure of gp41 from the HIV Envelope Glycoprotein
Chan, D. C., Fass, D., Berger, J. M., & Kim, P. S. (1997) · Cell · doi:10.1016/s0092-8674(00)80205-6 · Cited by 1,959
Atomic structure of the ectodomain from HIV-1 gp41
Weissenhorn, W., Dessen, A., Harrison, S. C., Skehel, J. J., & Wiley, D. C. (1997) · Nature · doi:10.1038/387426a0 · Cited by 1,622
Structure of influenza haemagglutinin at the pH of membrane fusion
Bullough, P. A., Hughson, F. M., Skehel, J. J., & Wiley, D. C. (1994) · Nature · doi:10.1038/371037a0 · Cited by 1,564
Chan, D. C., & Kim, P. S. (1998) · Cell · doi:10.1016/s0092-8674(00)81430-0 · Cited by 1,277
CD4-induced interaction of primary HIV-1 gp120 glycoproteins with the chemokine receptor CCR-5
Wu, L., Gerard, N. P., Wyatt, R., Choe, H., Parolin, C., Ruffing, N., Borsetti, A., Cardoso, A. A., Desjardin, E., Newman, W., et al. (1996) · Nature · doi:10.1038/384179a0 · Cited by 1,167
CD4-dependent, antibody-sensitive interactions between HIV-1 and its co-receptor CCR-5
Trkola, A., Dragic, T., Arthos, J., Binley, J. M., Olson, W. C., Allaway, G. P., Cheng-Mayer, C., Robinson, J., Maddon, P. J., & Moore, J. P. (1996) · Nature · doi:10.1038/384184a0 · Cited by 1,034
Kilby, J. M., Hopkins, S., Venetta, T. M., DiMassimo, B., Cloud, G. A., Lee, J. Y., Alldredge, L., Hunter, E., Lambert, D., Bolognesi, D., et al. (1998) · Nature Medicine · doi:10.1038/3293 · Cited by 987
Self-citationHuman Retroviruses and Aids - 1999
Kuiken, C., & Foley, B. (1999) · doi:10.2172/1186019 · Cited by 952
Wild, C. T., Shugars, D. C., Greenwell, T. K., McDanal, C. B., & Matthews, T. J. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.21.9770 · Cited by 931
Identification of the Envelope V3 Loop as the Primary Determinant of Cell Tropism in HIV-1
Hwang, S. S., Boyle, T. J., Lyerly, H. K., & Cullen, B. R. (1991) · Science · doi:10.1126/science.1905842 · Cited by 870
A spring-loaded mechanism for the conformational change of influenza hemagglutinin
Carr, C. M., & Kim, P. S. (1993) · Cell · doi:10.1016/0092-8674(93)90260-w · Cited by 857
Dual Infection of the Central Nervous System by AIDS Viruses with Distinct Cellular Tropisms
Koyanagi, Y., Miles, S., Mitsuyasu, R. T., Merrill, J. E., Vinters, H. V., & Chen, I. S. Y. (1987) · Science · doi:10.1126/science.3646751 · Cited by 817
A trimeric structural domain of the HIV-1 transmembrane glycoprotein
Lu, M., Blacklow, S. C., & Kim, P. S. (1995) · Nature Structural & Molecular Biology · doi:10.1038/nsb1295-1075 · Cited by 701
Expression cloning of new receptors used by simian and human immunodeficiency viruses
Deng, H., Unutmaz, D., KewalRamani, V. N., & Littman, D. R. (1997) · Nature · doi:10.1038/40894 · Cited by 684
Dissociation of gp120 from HIV-1 Virions Induced by Soluble CD4
Moore, J. P., McKeating, J. A., Weiss, R. A., & Sattentau, Q. J. (1990) · Science · doi:10.1126/science.2251501 · Cited by 576
O'Brien, W. A., Koyanagi, Y., Namazie, A., Zhao, J.-Q., Diagne, A., ldler, K., Zack, J. A., & Chen, I. S. Y. (1990) · Nature · doi:10.1038/348069a0 · Cited by 570
Self-citationAtomic structure of a thermostable subdomain of HIV-1 gp41
Tan, K., Liu, J.-H., Wang, J.-H., Shen, S., & Lu, M. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12303 · Cited by 532
Shioda, T., Levy, J. A., & Cheng‐Mayer, C. (1991) · Nature · doi:10.1038/349167a0 · Cited by 526
Cocchi, F., DeVico, A. L., Garzino-Demo, A., Cara, A., Gallo, R. C., & Lusso, P. (1996) · Nature Medicine · doi:10.1038/nm1196-1244 · Cited by 495
Capture of an early fusion-active conformation of HIV-1 gp41
Furuta, R. A., Wild, C. T., Weng, Y., & Weiss, C. D. (1998) · Nature Structural Biology · doi:10.1038/nsb0498-276 · Cited by 488
Wild, C., Oas, T., McDanal, C., Bolognesi, D., & Matthews, T. (1992) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.89.21.10537 · Cited by 485
Determinants of Human Immunodeficiency Virus Type 1 Resistance to gp41-Derived Inhibitory Peptides
Rimsky, L. T., Shugars, D. C., & Matthews, T. J. (1998) · Journal of Virology · doi:10.1128/jvi.72.2.986-993.1998 · Cited by 423
Sattentau, Q. J., Moore, J. P., Vignaux, F., Traincard, F., & Poignard, P. (1993) · Journal of Virology · doi:10.1128/jvi.67.12.7383-7393.1993 · Cited by 317
Chemokine Receptors: Keys to AIDS Pathogenesis?
Littman, D. R. (1998) · Cell · doi:10.1016/s0092-8674(00)81429-4 · Cited by 300
Macrophage tropism determinants of human immunodeficiency virus type 1 in vivo
Westervelt, P., Trowbridge, D. B., Epstein, L. G., Blumberg, B. M., Li, Y., Hahn, B. H., Shaw, G. M., Price, R. W., & Ratner, L. (1992) · Journal of Virology · doi:10.1128/jvi.66.4.2577-2582.1992 · Cited by 288
Self-citationMuñoz-Barroso, I., Durell, S., Sakaguchi, K., Appella, E., & Blumenthal, R. (1998) · The Journal of Cell Biology · doi:10.1083/jcb.140.2.315 · Cited by 280
Speck, R. F., Wehrly, K., Platt, E. J., Atchison, R. E., Charo, I. F., Kabat, D., Chesebro, B., & Goldsmith, M. A. (1997) · Journal of Virology · doi:10.1128/jvi.71.9.7136-7139.1997 · Cited by 275
Human retroviruses and AIDS 1994
Myers, G., Korber, B., Wain-Hobson, S., Jeang, K.-T., Henderson, L. E., & Pavlakis, G. N. (1995) · doi:10.2172/10116202 · Cited by 273
Identification of CXCR4 Domains That Support Coreceptor and Chemokine Receptor Functions
Doranz, B. J., Orsini, M. J., Turner, J. D., Hoffman, T. L., Berson, J. F., Hoxie, J. A., Peiper, S. C., Brass, L. F., & Doms, R. W. (1999) · Journal of Virology · doi:10.1128/jvi.73.4.2752-2761.1999 · Cited by 226
Kozak, S. L., Platt, E. J., Madani, N., Ferro, F. E., Peden, K., & Kabat, D. (1997) · Journal of Virology · doi:10.1128/jvi.71.2.873-882.1997 · Cited by 226
Wild, C., Dubay, J. W., Greenwell, T., Baird, T., Oas, T. G., McDanal, C., Hunter, E., & Matthews, T. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.26.12676 · Cited by 200
Self-citationBieniasz, P. D. (1997) · The EMBO Journal · doi:10.1093/emboj/16.10.2599 · Cited by 195
Dubay, J. W., Roberts, S. J., Brody, B., & Hunter, E. (1992) · Journal of Virology · doi:10.1128/jvi.66.8.4748-4756.1992 · Cited by 189
Self-citationJones, P. L. S. J., Korte, T., & Blumenthal, R. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.1.404 · Cited by 179
Hung, C., Heyden, N. V., & Ratner, L. (1999) · Journal of Virology · doi:10.1128/jvi.73.10.8216-8226.1999 · Cited by 121
Self-citationHIV-1 envelope determinants for cell tropism and chemokine receptor use
Hoffman, T. L., & Doms, R. W. (1999) · Molecular Membrane Biology · doi:10.1080/096876899294760 · Cited by 104
Smyth, R. J., Yi, Y., Singh, A., & Collman, R. G. (1998) · Journal of Virology · doi:10.1128/jvi.72.5.4478-4484.1998 · Cited by 101
The role of CD4 in HIV binding and entry
Sattentau, Q. J., & Moore, J. P. (1993) · Philosophical Transactions of the Royal Society B Biological Sciences · doi:10.1098/rstb.1993.0136 · Cited by 90
Inhibition of HIV-1 entry before gp41 folds into its fusion-active conformation
Kliger, Y., & Shai, Y. (2000) · Journal of Molecular Biology · doi:10.1006/jmbi.1999.3368 · Cited by 85
Willey, R. L., Martin, M. A., & Peden, K. (1994) · Journal of Virology · doi:10.1128/jvi.68.2.1029-1039.1994 · Cited by 79
Japour, A. J., Fiscus, S. A., Arduino, J. M., Mayers, D. L., Reichelderfer, P. S., & Kuritzkes, D. R. (1994) · Journal of Clinical Microbiology · doi:10.1128/jcm.32.9.2291-2294.1994 · Cited by 77
O’Brien, W. A., Sumner-Smith, M., Mao, S., Sadeghi, S., Zhao, J. Q., & Chen, I. S. (1996) · Journal of Virology · doi:10.1128/jvi.70.5.2825-2831.1996 · Cited by 76
Self-citationChemokines and coreceptors in HIV/SIV-host interactions.
Tl, H., & Doms, R. W. (1998) · PubMed · Cited by 67
Mapping genetic determinants for human immunodeficiency virus type 1 resistance to soluble CD4
O’Brien, W. A., Chen, I. S., Ho, D. D., & Daar, E. S. (1992) · Journal of Virology · doi:10.1128/jvi.66.5.3125-3130.1992 · Cited by 57
Self-citationLabrosse, B., Tréboute, C., & Alizon, M. (2000) · Journal of Virology · doi:10.1128/jvi.74.5.2142-2150.2000 · Cited by 51
Willey, R. L., & Martin, M. A. (1993) · Journal of Virology · doi:10.1128/jvi.67.6.3639-3643.1993 · Cited by 37
Derdeyn, C. A., Kilby, J. M., Miralles, G. D., Li, L., Sfakianos, G., Saag, M. S., Hockett, R. D., & Bucy, R. P. (1999) · The Journal of Infectious Diseases · doi:10.1086/315117 · Cited by 26
Self-citationThe Bis-Azo Compound FP-21399 Inhibits HIV-1 Replication by Preventing Viral Entry
Zhang, J. L., Choe, H., Dezube, B. J., Farzan, M., Sharma, P. L., Zhou, X. C., Chen, L. B., Ono, M., Gillies, S. D., Wu, Y., et al. (1998) · Virology · doi:10.1006/viro.1998.9115 · Cited by 23
Cited by
Wei, X., Decker, J. M., Liu, H., Zhang, Z., Arani, R. B., Kilby, J. M., Saag, M. S., Wu, X., Shaw, G. M., & Kappes, J. C. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.6.1896-1905.2002 · Cited by 1,569
“(6), these differences appear not to affect susceptibility to T-20.”
BackgroundSelf-citationSanders, R. W., Derking, R., Cupo, A., Julien, J.-P., Yasmeen, A., de Val, N., Kim, H. J., Blattner, C., de la Peña, A. T., Korzun, J., et al. (2013) · PLoS Pathogens · doi:10.1371/journal.ppat.1003618 · Cited by 935
HIV-1 Antiretroviral Drug Therapy
Arts, E. J., & Hazuda, D. J. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007161 · Cited by 851
RNA motif discovery by SHAPE and mutational profiling (SHAPE-MaP)
Siegfried, N. A., Busan, S., Rice, G. M., Nelson, J. A. E., & Weeks, K. M. (2014) · Nature Methods · doi:10.1038/nmeth.3029 · Cited by 654
Seaman, M. S., Janes, H., Hawkins, N., Grandpre, L. E., Devoy, C., Giri, A., Coffey, R. T., Harris, L., Wood, B., Daniels, M. G., et al. (2010) · Journal of Virology · doi:10.1128/jvi.02108-09 · Cited by 632
Metadata
- Authors
- Derdeyn, C. A., Decker, J. M., Sfakianos, J. N., Wu, X., O'Brien, W. A., Ratner, L., Kappes, J. C., Shaw, G. M., & Hunter, E.
- Venue
- Journal of Virology
- Publisher
- American Society for Microbiology
- Published
- 2000-09-15
- Volume
- 74
- Issue
- 18
- Pages
- 8358-8367
- ISSN
- 0022-538X (ISSN-L)
- 1098-5514
- OpenAlex
- W2153747683
- Cited by
- 742
- References
- 54
- FWCI
- 3.30
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.